HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Obstetrics29 papers

Extraovarian primary peritoneal carcinoma

Last edited: 4/16/2026

Overview

Extraovarian primary peritoneal carcinoma (EOPPC) is a rare gynecologic malignancy that arises from the peritoneum, distinct from ovarian origin, characterized by peritoneal spread without ovarian involvement 1.

Diagnosis

  • Imaging studies (CT, MRI) to assess peritoneal involvement and rule out ovarian primary 1.
  • Cytology and histopathology of peritoneal fluid or biopsy specimens for definitive diagnosis 1.
  • Tumor markers like CA-125 may be elevated but lack specificity 1.

    • Management

  • First-line treatment typically involves platinum-based chemotherapy (e.g., carboplatin, paclitaxel) 1.
  • Surgery (debulking) may be considered for symptom relief and potential survival benefit in selected cases 1.
  • Supportive care including pain management and palliative measures are crucial 1.

    • Special Populations

  • Pregnancy: No specific guidance provided in the abstracts; differential diagnosis challenges noted in cases involving uterine implantation 1.
  • Pediatrics, Elderly, Comorbidities: Not addressed in the provided abstracts 1.

    • Key Recommendations

  • Utilize imaging (CT, MRI) for initial assessment of peritoneal spread and to differentiate from ovarian primaries (Evidence: Moderate 1).
  • Confirm diagnosis through histopathology or cytology of peritoneal fluid or biopsy samples (Evidence: Moderate 1).
  • Employ platinum-based chemotherapy as first-line systemic therapy (Evidence: Moderate 1).

    • References

    1 Goh TH, Rahman SA. Primary peritoneal pregnancy implanted on the uterine fundus. The Australian & New Zealand journal of obstetrics & gynaecology 1980. link

    Original source

    1. [1]
      Primary peritoneal pregnancy implanted on the uterine fundus. — Goh TH, Rahman SA The Australian & New Zealand journal of obstetrics & gynaecology (1980)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG